Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/21/2022 69 5
Ritonavir Emergency use authorization Used to treat other disease Antiviral Nov/02/2021 27 13
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 46
IVIg Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/24/2021 7 2
Amentoflavone Potential treatment - theoretical effect Natural product Antiviral Feb/16/2021 4 0
Hordatine A Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 1 0
Hordatine B Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 1 0
10-hydroxyusambarensine Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 1 0
Cryptospirolepine Potential treatment - theoretical effect Natural product Antiviral Oct/22/2020 1 0